VFA
BSX icon

Values First Advisors’s Boston Scientific BSX Stock Holding History

Values First Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,280
Closed -$206K – 188
2026
Q1 		$206K Buy
3,280
+70
+2% +$5.6K 0.11% 159
2025
Q4 		$306K Buy
3,210
+275
+9% +$27K 0.16% 137
2025
Q3 		$287K Sell
2,935
-155
-5% -$16.1K 0.15% 137
2025
Q2 		$332K Sell
3,090
-18
-0.6% -$1.82K 0.18% 141
2025
Q1 		$313K Sell
3,108
-2
-0.1% -$201 0.18% 138
2024
Q4 		$278K Buy
3,110
+2,771
+817% +$244K 0.15% 147
2024
Q3 		$28.4K Buy
+339
New +$26.7K 0.02% 258

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Values First Advisors's BSX Position: Q2 2026 in Review

Values First Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,280 shares — an estimated $206K sold.

Values First Advisors first reported a position in BSX in Q3 2024 and held it in 7 quarters. The position peaked at $332K in Q2 2025. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Values First Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Values First Advisors sold 3,280 Boston Scientific shares in Q2 2026, an estimated $206K.
  • Values First Advisors first reported a position in Boston Scientific in Q3 2024 and held it in 7 quarters.
  • Values First Advisors's Boston Scientific position peaked at $332K in Q2 2025.
  • 1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Values First Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.